PUBLISHER: The Business Research Company | PRODUCT CODE: 1945359
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945359
Implantable remote patient monitoring devices are medical technologies surgically inserted into a patient's body to continuously measure physiological parameters such as heart rhythm, blood pressure, and glucose levels. These devices feature built-in sensors and wireless communication capabilities, allowing them to capture real-time health data and transmit it to healthcare professionals. This facilitates ongoing monitoring, early detection of potential health problems, and prompt medical intervention, while also reducing the need for frequent hospital visits.
The key product categories of implantable remote patient monitoring devices include blood glucose monitoring systems, cardiac monitoring devices, weight monitoring devices, and others. They are utilized in the management of cardiovascular diseases, neurological disorders, diabetes, and various other conditions, serving end users such as hospitals, ambulatory surgical centers, home care environments, and beyond.
Tariffs are impacting the implantable remote patient monitoring devices market by increasing the cost of imported sensors, electronic components, and wireless modules. Segments such as cardiac monitoring devices and continuous glucose monitoring systems are particularly affected, with regions like Asia-Pacific, especially China and India, facing significant import duties. This has led to higher device costs and supply chain delays. On the positive side, tariffs are encouraging local manufacturing, innovation in component sourcing, and expansion of domestic production capabilities.
The implantable remote patient monitoring devices market research report is one of a series of new reports from The Business Research Company that provides implantable remote patient monitoring devices market statistics, including implantable remote patient monitoring devices industry global market size, regional shares, competitors with a implantable remote patient monitoring devices market share, detailed implantable remote patient monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the implantable remote patient monitoring devices industry. This implantable remote patient monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The implantable remote patient monitoring devices market size has grown exponentially in recent years. It will grow from $10.26 billion in 2025 to $12.51 billion in 2026 at a compound annual growth rate (CAGR) of 21.9%. The growth in the historic period can be attributed to limited awareness of remote monitoring benefits, reliance on conventional in-hospital monitoring, slow adoption of implantable devices, restricted wireless connectivity, high cost of early monitoring devices.
The implantable remote patient monitoring devices market size is expected to see exponential growth in the next few years. It will grow to $27.48 billion in 2030 at a compound annual growth rate (CAGR) of 21.7%. The growth in the forecast period can be attributed to technological advancements in implantable sensors, increasing prevalence of chronic diseases, integration with telemedicine platforms, rising geriatric population, supportive government reimbursement policies. Major trends in the forecast period include increasing adoption of continuous glucose monitoring devices, growth in implantable cardiac monitoring systems, rising use of smart weight monitoring devices, expansion of remote home care monitoring solutions, enhanced focus on real-time data transmission and patient safety.
The growing adoption of telehealth services is expected to drive the growth of the implantable remote patient monitoring devices market in the coming years. Telehealth services encompass healthcare delivery provided remotely through phone calls, video consultations, or digital applications, allowing patients to access medical care without visiting hospitals or clinics. The increased adoption of telehealth services is driven by the rising demand for continuous and real-time health monitoring among patients with chronic conditions, as it facilitates timely medical interventions while reducing the need for frequent in-person visits. Telehealth services complement implantable remote patient monitoring devices by enabling real-time data transmission between patients and healthcare providers, supporting prompt clinical decision-making and minimizing reliance on face-to-face consultations. They further enhance chronic disease management by providing continuous monitoring and early intervention, thereby improving healthcare efficiency and patient convenience. For example, in April 2023, according to FAIR Health Inc., a US-based non-profit organization, national telehealth utilization rose by 7.3% in 2023, increasing from 5.5% of medical claim lines in December 2022 to 5.9% in January 2023. Therefore, the increasing adoption of telehealth services is fueling the growth of the implantable remote patient monitoring devices market.
Major companies operating in the implantable remote patient monitoring devices market are prioritizing the development of advanced solutions, such as implantable cardiac monitors, to improve the precision and effectiveness of cardiac arrhythmia monitoring. An implantable cardiac monitor (ICM), also referred to as an implantable loop recorder (ILR), is a compact device implanted beneath the skin, typically in the left chest region, that continuously tracks and records the heart's electrical activity over extended durations. For instance, in June 2023, Biotronik AG, a Switzerland-based medical technology company, introduced the BIOMONITOR IV implantable cardiac monitor. This advanced ICM integrates BIOTRONIK's SmartECG technology with artificial intelligence to reduce false-positive detections by 86% while maintaining 98% sensitivity for true arrhythmic events. The device is also capable of differentiating between premature atrial contractions (PACs) and premature ventricular contractions (PVCs), equipping healthcare professionals with enhanced tools for accurate diagnosis and risk stratification.
In September 2023, FluidAI Medical Inc., a Canada-based healthcare technology company, entered into a partnership with Medtronic Canada ULC to support at-home remote patient monitoring. Through this collaboration, FluidAI Medical Inc. aimed to expand its Stream platform to deliver remote patient monitoring and predictive analytics through Medtronic's Continuous Connected Patient Care (CCPC) initiative, enabling seamless transitions of care from hospital to home. Medtronic Canada ULC is a Canada-based healthcare technology company specializing in medical devices, remote monitoring systems, and integrated digital care solutions.
Major companies operating in the implantable remote patient monitoring devices market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Dexcom Inc., LivaNova PLC, MicroPort Scientific Corporation, NeuroPace Inc., Profusa Inc., Senseonics Holdings Inc., Xeltis AG, GlySens Inc., Biotronik SE & Co KG, Impulse Dynamics NV, CVRx Inc., Vectorious Medical Technologies, EBR Systems Inc., Axonics Modulation Technologies Inc., Synchron Inc., Neuralink Corp, Orchestra BioMed Holdings Inc., Second Sight Medical Products Inc.
North America was the largest region in the implantable remote patient monitoring devices market in 2025. The regions covered in the implantable remote patient monitoring devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the implantable remote patient monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The implantable remote patient monitoring devices market consists of revenues earned by entities by providing services such as continuous health monitoring, early detection of health problems, remote data transmission, real-time alerts and reduced hospital visits. The market value includes the value of related goods sold by the service provider or included within the service offering. The implantable remote patient monitoring devices market also includes sales of implantable hemodynamic monitors, implantable pulmonary artery pressure sensors, insertable loop recorders (ILRs), subcutaneous electrocardiogram (ECG) monitors, and long-term heart rhythm monitoring devices. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Implantable Remote Patient Monitoring Devices Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses implantable remote patient monitoring devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for implantable remote patient monitoring devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The implantable remote patient monitoring devices market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.